Kate Lindley Baron-Cohen, Ph.D., is a Postdoctoral Researcher in developmental and clinical psychology at University College London, where she is leading several projects investigating risk ...

Recent Company Developments and Updates Advancing AMT-130 Toward Accelerated Approval for Huntington's disease In April 2025, the FDA granted Breakthrough Therapy designation to AMT-130 based on ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Credit: Mashable ...